Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-07-15 | New | $4,679,395 | $4,679,395 | Debt Only | 06b | SEC link |
| 2023-01-12 | Amended | $5,005,000 | $5,005,000 | Equity Only | 06b | SEC link |
| 2022-12-29 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2020-12-09 | New | $45,187,328 | $45,187,328 | Equity Only | 06b | SEC link |
| 2020-05-06 | New | $4,250,000 | $4,250,000 | Equity and Debt | 06b | SEC link |
| Name | Role |
|---|---|
| Brent Ahrens | Director |
| William Harrington, Md, Mba | Director |
| Daniel Hetu, Md, Mba | Director |
| Keith A. Katkin | Director |
| John Pacifico | Director |
| Dennis Podlesak | Director, Executive |
| Lynne R. Rollins | Executive |
| Brian Taylor Slingsby, Md, Phd, Mph | Director |
| Eckard Weber, M.D. | Director, Executive |
| Eckard Weber, Md | Director, Executive |